Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript February 29, 2024 Catalyst Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Catalyst Pharmaceuticals Inc. Fourth Quarter and Full Year 2023 Financial Results Conference […]

Related Keywords

Japan ,United States ,American ,Japanese ,Richard Daly ,Michael Kalb ,Mike Kalb ,Dydo Pharma ,Steven Miller ,Exchange Commission ,Chief Operating Officer ,Chief Scientific Officer ,Lambert Eaton Myasthenic Syndrome ,Japan Dydo Pharma ,Duchenne Muscular Dystrophy ,Chief Financial ,North American ,Annual Report ,Paying Countries ,Low Humidity You Can Retire ,